Barriers to compliance with screening guidelines for diabetic retinopathy.
about
Treatment of diabetic retinopathy: Recent advances and unresolved challengesDilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic accessAnti-angiogenic therapy of proliferative diabetic retinopathy.Pharmacologic therapy for diabetic retinopathy.Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathyAutomated detection of proliferative retinopathy in clinical practiceVision is precious: a successful behavioral intervention to increase the rate of screening for diabetic retinopathy for inner-city adultsDiabetic retinopathy: the unmet needs for screening and a review of potential solutions.Factors associated with diabetic retinopathy and nephropathy screening in Korea: the Third and Fourth Korea National Health and Nutrition Examination Survey (KNHANES III and IV)Retinopathy of prematurity management using single-image vs multiple-image telemedicine examinationsPrimary care physicians' knowledge of the ophthalmic effects of diabetes.EyePACS: an adaptable telemedicine system for diabetic retinopathy screening.Diabetic retinopathy: Knowledge, awareness and practices of physicians in primary-care centers in Riyadh, Saudi Arabia.Feasibility of telemedicine in detecting diabetic retinopathy and age-related macular degeneration.Disparities in Adherence to Screening Guidelines for Diabetic Retinopathy in the United States: A Comprehensive Review and Guide for Future Directions.Prevalence of diabetic retinopathy and eye care in a rural area of Spain.Reflex-free digital fundus photography using a simple and portable camera adaptor system. A viable alternative.Report on the creation of a diabetes register and retinopathy screening outcomes in the Mid-West of Ireland.Compliance with eye screening examinations among diabetic patients at a Tanzanian referral hospital.Inter-relationships between lifestyle and diabetes mellitus, overweight/obesity and hypertension in Nigeria.Impact of geographic density of eye care professionals on eye care among adults with diabetes.Smartphones, tele-ophthalmology, and VISION 2020.Diabetic retinopathy screening in incident diabetes mellitus type 2 in Germany between 2004 and 2013 - A prospective cohort study based on health claims data.Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy.
P2860
Q28067491-CB3AA2B3-D510-4094-9BF4-2EB182A1A792Q30390156-1115CFAE-59BA-4180-9E44-8843B8B0118DQ30666418-F51916E0-EF70-4905-87EB-15887D539C43Q33194915-4E526923-0481-4AF3-B137-4ECAF46A7411Q34657059-DA9697C7-5AE7-42F4-A296-259DB068C673Q34996605-D454583B-4F23-4215-A275-231479A4517CQ36092061-D84B1DC7-76D2-4AC2-9C80-42C0DDF8F230Q36471532-2FC7FFEB-D82B-43B7-8F8E-BE21FCA9ABC5Q36917131-CB90AC9D-51D1-445D-96A4-EB702AB93AECQ36966266-087061BD-B361-458A-BB62-1CB897D0B9B0Q37393302-0D48EC13-AE80-4A76-A480-08AF39C8F7B9Q37404429-EC3AF2CE-7313-4291-8BD2-4264F75A6FEAQ37703546-E7AA5446-01FE-4B10-8764-91C07A3658DDQ38156478-EDE1B9F1-E551-4942-A2B7-3CBDF5AC8F98Q38818027-1889FAA8-9D75-4965-8F38-17956C74D87DQ39604543-7EBDCAC8-9C8E-46CD-A439-66A1E71D85C8Q40015329-FE00739C-D790-43F1-9214-C5BC327E5AD4Q41571864-2C4D1C47-A193-4A53-9622-D3A2CA2E8B0BQ43945178-780C511E-49F7-459D-B884-741C13B2AEF9Q44206592-005EE435-799D-476D-B426-F1CA72FA688FQ48557404-BD4F024B-202C-492C-8F53-70FDDAABD845Q49292697-F0A30DFA-2BF2-4AB1-957F-975599DC8180Q55241071-30777CB4-03DD-4A9B-A0DD-64405133534CQ55347948-85F80B69-8A9B-4598-A36E-79C72FB6CB5C
P2860
Barriers to compliance with screening guidelines for diabetic retinopathy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Barriers to compliance with screening guidelines for diabetic retinopathy.
@en
Barriers to compliance with screening guidelines for diabetic retinopathy.
@nl
type
label
Barriers to compliance with screening guidelines for diabetic retinopathy.
@en
Barriers to compliance with screening guidelines for diabetic retinopathy.
@nl
prefLabel
Barriers to compliance with screening guidelines for diabetic retinopathy.
@en
Barriers to compliance with screening guidelines for diabetic retinopathy.
@nl
P2093
P2860
P356
P1476
Barriers to compliance with screening guidelines for diabetic retinopathy.
@en
P2093
P2860
P356
10.1076/OPEP.6.1.61.1563
P577
1999-03-01T00:00:00Z